Research

New radiation therapy approach for treating lung cancers

VUMC researchers tested a treatment combining immunotherapy and online adaptive radiotherapy, which is tailored to real-time tumor changes during the treatment plan.

Zinc deficiency promotes Acinetobacter lung infection: study

The study findings point to the potential of interleukin-13 antibodies — approved for use in humans — as a treatment to protect against bacterial pneumonia in patients with zinc deficiency.

Jennifer Herington, PhD, and Todd Giorgio, PhD, during their in-person visit to ARPA-H in July.

VUMC receives $3.3 million ARPA-H award to develop at-home therapy for preterm labor

This project will be the first to apply drug conjugates in the field of obstetrics.

(iStock)

Studies to explore molecular drivers of pulmonary diseases

Three grants, totaling over $22 million, were awarded by the National Institutes of Health’s National Heart, Lung, and Blood Institute and will be led by a team of VUMC investigators.

New Video: Only half of young cancer patients report discussing fertility preservation

Young patients with thyroid, lung, ovarian and colorectal cancers reported the lowest prevalence of a fertility preservation discussion.

GLP-1 medicines are focus of Discovery Lecture on Nov. 21

Daniel Drucker, MD, a pioneering scientist whose research contributed to the development of the blockbuster GLP-1 medicines used to treat diabetes and obesity, was listed by TIME magazine as one of the 100 Most Influential People of 2024.

1 12 13 14 15 16 135